We serve N-([1,1′-biphenyl]-4-yl)-N-(9,9-dimethyl-9H-fluoren-2-yl)-9,9′-spirobi[fluoren]-2-amine CAS:1364602-88-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
9,9'-Spirobi[9H-fluoren]-2-amine,N-[1,1'-biphenyl]-4-yl-N-(9,9-dimethyl-9H-fluoren-2-yl)-
Items of Analysis | Standard of Analysis | Test Results |
Appearance | White powder | Conform |
Assay (HPLC) | ≥98.0% | 98.4% |
Melting point | 165.0-169.0℃ | 166.4-168.2℃ |
Conclusion | Conforms to Factory Standard |
Contact us for information like N-([1,1′-biphenyl]-4-yl)-N-(9,9-dimethyl-9H-fluoren-2-yl)-9,9′-spirobi[fluoren]-2-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9,9′-Spirobi[9H-fluoren]-2-amine,N-[1,1′-biphenyl]-4-yl-N-(9,9-dimethyl-9H-fluoren-2-yl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9,9′-Spirobi[9H-fluoren]-2-amine,N-[1,1′-biphenyl]-4-yl-N-(9,9-dimethyl-9H-fluoren-2-yl)- Use and application,9,9′-Spirobi[9H-fluoren]-2-amine,N-[1,1′-biphenyl]-4-yl-N-(9,9-dimethyl-9H-fluoren-2-yl)- technical grade,usp/ep/jp grade.
Related News: “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.Methyl 4-bromo-3-nitrobenzoate manufacturer “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.2,3,3-trimethyl-1-(5-methylcarbonyloxypentyl)-3H-benzo[b]azolium iodide supplier Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant.benzyl Nα-(tert-butyloxycarbonyl)-L-α-aminoadipo-δ-hydroxamate vendor These include: high-barrier generic drug substances and commonly used generic drug substances.From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry.